Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$93.6 - $388.02 $172,598 - $715,508
1,844 New
1,844 $698 Million
Q4 2023

Aug 14, 2024

BUY
$306.88 - $380.0 $536,119 - $663,860
1,747 Added 121.49%
3,185 $1.21 Billion
Q3 2023

Aug 14, 2024

SELL
$315.92 - $397.36 $63,815 - $80,266
-202 Reduced 12.32%
1,438 $457 Million
Q2 2023

Aug 14, 2024

BUY
$346.15 - $392.09 $512,301 - $580,293
1,480 Added 925.0%
1,640 $629 Million
Q1 2023

Aug 14, 2024

SELL
$323.56 - $373.36 $40,121 - $46,296
-124 Reduced 43.66%
160 $59.7 Million
Q2 2022

Aug 14, 2024

BUY
$301.4 - $428.42 $15,069 - $21,421
50 Added 21.37%
284 $88.9 Million
Q1 2022

Aug 14, 2024

BUY
$379.46 - $424.54 $88,793 - $99,342
234 New
234 $97.7 Million
Q4 2021

Aug 30, 2024

SELL
$373.53 - $434.12 $373 - $434
-1 Reduced 0.43%
234 $98 Million
Q2 2021

Aug 30, 2024

BUY
$372.36 - $412.07 $87,504 - $96,836
235 New
235 $93 Million
Q1 2021

Aug 30, 2024

SELL
$357.26 - $392.57 $6,430 - $7,066
-18 Reduced 4.46%
386 $148 Million
Q4 2020

Aug 30, 2024

BUY
$319.05 - $363.32 $122,834 - $139,878
385 Added 2026.32%
404 $147 Million
Q3 2020

Aug 30, 2024

SELL
$280.08 - $347.78 $5,321 - $6,607
-19 Reduced 50.0%
19 $6.41 Million
Q2 2020

Aug 30, 2024

BUY
$270.93 - $320.3 $7,586 - $8,968
28 Added 280.0%
38 $10.8 Million
Q1 2020

Aug 30, 2024

BUY
$243.44 - $359.98 $2,434 - $3,599
10 New
10 $2.76 Million
Q3 2018

Aug 30, 2024

SELL
$236.3 - $277.15 $11,815 - $13,857
-50 Closed
0 $0
Q1 2018

Aug 30, 2024

BUY
$218.74 - $251.43 $10,937 - $12,571
50 New
50 $11.4 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.